Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1979-2001
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1979
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1979
Figure 1 Modeling time point, drug treatment, and grouping of animal models.
HMGB1: High-mobility group box 1; BMSC-exo: Bone marrow mesenchymal stem cell derived exosomes; NC: Negative control; ICH: Intracerebral hemorrhage.
- Citation: Wang YY, Li K, Wang JJ, Hua W, Liu Q, Sun YL, Qi JP, Song YJ. Bone marrow-derived mesenchymal stem cell-derived exosome-loaded miR-129-5p targets high-mobility group box 1 attenuates neurological-impairment after diabetic cerebral hemorrhage. World J Diabetes 2024; 15(9): 1979-2001
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1979.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1979